Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Puma Biotechnology ROA 2008-2020 | PBYI

For a detailed definition, formula and example for ROA, check out our new background page here.
Current and historical return on assets (ROA) values for Puma Biotechnology (PBYI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Puma Biotechnology ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $-0.06B $0.26B -22.70%
2020-06-30 $-0.04B $0.26B -17.55%
2020-03-31 $-0.08B $0.23B -35.16%
2019-12-31 $-0.08B $0.24B -28.90%
2019-09-30 $-0.10B $0.23B -35.78%
2019-06-30 $-0.09B $0.24B -34.68%
2019-03-31 $-0.10B $0.33B -37.75%
2018-12-31 $-0.11B $0.26B -50.90%
2018-09-30 $-0.15B $0.23B -73.46%
2018-06-30 $-0.21B $0.23B -112.06%
2018-03-31 $-0.24B $0.17B -140.67%
2017-12-31 $-0.29B $0.17B -158.27%
2017-09-30 $-0.30B $0.18B -145.94%
2017-06-30 $-0.29B $0.17B -149.29%
2017-03-31 $-0.28B $0.22B -144.00%
2016-12-31 $-0.28B $0.25B -145.22%
2016-09-30 $-0.27B $0.13B -141.87%
2016-06-30 $-0.26B $0.17B -117.12%
2016-03-31 $-0.26B $0.21B -101.28%
2015-12-31 $-0.24B $0.24B -83.42%
2015-09-30 $-0.22B $0.27B -83.82%
2015-06-30 $-0.20B $0.30B -82.56%
2015-03-31 $-0.17B $0.33B -80.65%
2014-12-31 $-0.14B $0.16B -75.63%
2014-09-30 $-0.11B $0.17B -64.16%
2014-06-30 $-0.09B $0.20B -56.06%
2014-03-31 $-0.06B $0.22B -44.44%
2013-12-31 $-0.06B $0.10B -45.08%
2013-09-30 $-0.06B $0.12B -45.52%
2013-06-30 $-0.07B $0.13B -63.89%
2013-03-31 $-0.08B $0.14B -80.43%
2012-12-31 $-0.08B $0.15B -105.26%
2012-09-30 $-0.06B $0.04B -134.04%
2012-06-30 $-0.04B $0.04B -97.37%
2012-03-31 $-0.02B $0.05B -81.48%
2011-12-31 $-0.01B $0.06B -72.73%
2011-09-30 $0.00B $0.00B nan%
2011-06-30 $0.00B $0.00B nan%
2011-03-31 $0.00B $0.00B nan%
2010-12-31 $0.00B $0.00B nan%
2010-09-30 $0.00B $0.00B nan%
2010-06-30 $0.00B $0.00B nan%
2010-03-31 $0.00B $0.00B nan%
2009-12-31 $0.00B $0.00B nan%
2009-09-30 $0.00B $0.00B nan%
2009-06-30 $0.00B $0.00B nan%
2009-03-31 $0.00B $0.00B nan%
2008-12-31 $0.00B $0.00B nan%
2008-06-30 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.437B $0.272B
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the acquisition, in-licensing, development and commercialization of novel therapeutics for the treatment of cancer. Its products under development include PB272 (oral neratinib) for the treatment of patients with human epidermal growth factor receptor type 2 (HER2) positive metastatic breast cancer and gastric cancer and PB272 (neratinib intravenous) for the treatment of patients with advanced cancer. Puma Biotechnology, Inc. is headquartered in Los Angeles, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $149.383B 10.65
Amgen (AMGN) United States $140.687B 14.71
CSL (CSLLY) Australia $96.127B 0.00
Gilead Sciences (GILD) United States $78.220B 10.40
Vertex Pharmaceuticals (VRTX) United States $58.800B 27.34
Regeneron Pharmaceuticals (REGN) United States $55.264B 19.60
Illumina (ILMN) United States $54.172B 74.51
Moderna (MRNA) United States $51.332B 0.00
Biogen (BIIB) United States $43.131B 7.66
Alexion Pharmaceuticals (ALXN) United States $34.282B 13.66
Seagen (SGEN) United States $31.812B 83.74
BeiGene (BGNE) Cayman Islands $30.549B 0.00
Genmab (GMAB) Denmark $28.919B 34.20
Genmab (GNMSF) Denmark $27.046B 6.23
BioNTech SE (BNTX) Germany $23.950B 0.00
Exact Sciences (EXAS) United States $22.156B 0.00
Incyte (INCY) United States $20.156B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.178B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.067B 68.51
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.844B 0.00
Horizon Therapeutics Public (HZNP) Ireland $17.416B 24.89
Guardant Health (GH) United States $15.723B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $14.956B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.769B 98.02
ARGENX SE-ADR (ARGX) Netherlands $13.358B 0.00
Bio-Techne Corp (TECH) United States $13.019B 83.26
QIAGEN (QGEN) Netherlands $12.114B 27.28
Repligen (RGEN) United States $11.168B 158.40
Mirati Therapeutics (MRTX) United States $10.748B 0.00
Fate Therapeutics (FATE) United States $10.242B 0.00
Twist Bioscience (TWST) United States $9.209B 0.00
Adaptive Biotechnologies (ADPT) United States $8.979B 0.00
Denali Therapeutics (DNLI) United States $8.873B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.658B 0.00
Ascendis Pharma (ASND) Denmark $8.654B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.538B 0.00
Novavax (NVAX) United States $8.275B 0.00
Acceleron Pharma (XLRN) United States $7.650B 0.00
Exelixis (EXEL) United States $7.378B 49.54
Sarepta Therapeutics (SRPT) United States $7.094B 0.00
Galapagos (GLPG) Belgium $6.654B 0.00
Beam Therapeutics (BEAM) United States $6.453B 0.00
Halozyme Therapeutics (HALO) United States $6.360B 294.06
Amicus Therapeutics (FOLD) United States $6.069B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.964B 17.44
NeoGenomics (NEO) United States $5.938B 1782.67
Blueprint Medicines (BPMC) United States $5.713B 18.91
Emergent Biosolutions (EBS) United States $5.617B 18.43
Certara (CERT) United States $5.252B 0.00
Eidos Therapeutics (EIDX) United States $4.994B 0.00
Intellia Therapeutics (NTLA) United States $4.921B 0.00
Editas Medicine (EDIT) United States $4.732B 0.00
Arena Pharmaceuticals (ARNA) United States $4.686B 0.00
Vir Biotechnology (VIR) United States $4.648B 0.00
China Biologic Products (CBPO) China $4.647B 30.12
Arvinas (ARVN) United States $4.247B 0.00
Reata Pharmaceuticals (RETA) United States $4.094B 0.00
Legend Biotech (LEGN) United States $3.813B 0.00
Insmed (INSM) United States $3.807B 0.00
MorphoSys AG (MOR) Germany $3.761B 136.14
Alkermes (ALKS) Ireland $3.501B 34.38
Bluebird Bio (BLUE) United States $3.441B 0.00
Global Blood Therapeutics (GBT) United States $3.076B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.913B 0.00
I-Mab (IMAB) China $2.839B 0.00
Intra-Cellular Therapies (ITCI) United States $2.737B 0.00
Zymeworks (ZYME) Canada $2.540B 0.00
Arcus Biosciences (RCUS) United States $2.521B 0.00
Seres Therapeutics (MCRB) United States $2.437B 0.00
Amarin (AMRN) Ireland $2.397B 0.00
Sangamo Therapeutics (SGMO) United States $2.290B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.273B 0.00
Sorrento Therapeutics (SRNE) United States $2.101B 0.00
Viela Bio (VIE) United States $2.010B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.978B 16.38
Ligand Pharmaceuticals (LGND) United States $1.966B 50.95
Scholar Rock Holding (SRRK) United States $1.953B 0.00
Myriad Genetics (MYGN) United States $1.940B 0.00
NantKwest (NK) United States $1.932B 0.00
Revance Therapeutics (RVNC) United States $1.919B 0.00
Genetron Holdings (GTH) China $1.878B 0.00
REGENXBIO (RGNX) United States $1.869B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.827B 0.00
NGM Biopharmaceuticals (NGM) United States $1.787B 0.00
Vericel (VCEL) United States $1.750B 0.00
PHARMA MAR SA (PHMMF) Spain $1.746B 0.00
UniQure (QURE) Netherlands $1.694B 0.00
Precigen (PGEN) United States $1.597B 0.00
Inovio Pharmaceuticals (INO) United States $1.587B 0.00
Heska (HSKA) United States $1.529B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.525B 0.00
Castle Biosciences (CSTL) United States $1.524B 0.00
Codexis (CDXS) United States $1.521B 0.00
Zealand Pharma (ZEAL) Denmark $1.496B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.488B 0.00
Travere Therapeutics (TVTX) United States $1.487B 0.00
Mersana Therapeutics (MRSN) United States $1.422B 0.00
Cytokineticsorporated (CYTK) United States $1.401B 0.00
Cellectis S.A (CLLS) France $1.315B 0.00
Coherus BioSciences (CHRS) United States $1.296B 8.57
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Antibe Therapeutics (ATBPF) Canada $1.254B 0.00
Frequency Therapeutics (FREQ) United States $1.240B 0.00
Alector (ALEC) United States $1.231B 0.00
Epizyme (EPZM) United States $1.215B 0.00
Adverum Biotechnologies (ADVM) United States $1.165B 0.00
Mesoblast (MESO) Australia $1.155B 0.00
Athenex (ATNX) United States $1.088B 0.00
Northwest Biotherapeutics (NWBO) United States $1.083B 0.00
Bionano Genomics (BNGO) United States $1.065B 0.00
MiMedx (MDXG) United States $1.014B 0.00
Sutro Biopharma (STRO) United States $1.001B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.992B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.976B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.973B 0.00
Morphic Holding (MORF) United States $0.970B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.965B 0.00
Compugen (CGEN) Israel $0.924B 0.00
Pliant Therapeutics (PLRX) United States $0.918B 0.00
Pharming Group (PHGUF) Netherlands $0.914B 24.33
Cara Therapeutics (CARA) United States $0.899B 0.00
Protagonist Therapeutics (PTGX) United States $0.874B 0.00
Kadmon Holdings (KDMN) United States $0.811B 0.00
Avid Bioservices (CDMO) United States $0.806B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.794B 0.00
MannKind (MNKD) United States $0.786B 0.00
VBI Vaccines (VBIV) United States $0.779B 0.00
Syros Pharmaceuticals (SYRS) United States $0.777B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.765B 38.83
ZIOPHARM Oncology Inc (ZIOP) United States $0.752B 0.00
Celldex Therapeutics (CLDX) United States $0.711B 0.00
Albireo Pharma (ALBO) United States $0.711B 0.00
AnaptysBio (ANAB) United States $0.701B 0.00
Curis (CRIS) United States $0.693B 0.00
Cardiff Oncology (CRDF) United States $0.691B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.682B 0.00
Merus (MRUS) Netherlands $0.666B 0.00
Agenus (AGEN) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
MeiraGTx Holdings (MGTX) United States $0.631B 0.00
Affimed (AFMD) Germany $0.621B 0.00
Five Prime Therapeutics (FPRX) United States $0.607B 0.00
Anika Therapeutics (ANIK) United States $0.583B 78.85
Prothena (PRTA) Ireland $0.575B 0.00
Dynavax Technologies (DVAX) United States $0.566B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.556B 0.00
Pandion Therapeutics (PAND) United States $0.555B 0.00
Precision BioSciences (DTIL) United States $0.545B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.545B 0.00
Cel-Sci (CVM) United States $0.536B 0.00
Clovis Oncology (CLVS) United States $0.526B 0.00
Geron (GERN) United States $0.526B 0.00
AquaBounty Technologies (AQB) United States $0.511B 0.00
Starpharma Holdings (SPHRY) Australia $0.508B 0.00
FORTE BIOSCIENC (FBRX) United States $0.487B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.467B 0.00
Amryt Pharma (AMYT) United Kingdom $0.465B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.460B 0.00
Spero Therapeutics (SPRO) United States $0.452B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.451B 0.00
XOMA (XOMA) United States $0.441B 0.00
BioDelivery Sciences (BDSI) United States $0.440B 20.71
AC Immune SA (ACIU) Switzerland $0.439B 0.00
WAVE Life Sciences (WVE) Singapore $0.438B 0.00
UROGEN PHARMA (URGN) United States $0.437B 0.00
Kala Pharmaceuticals (KALA) United States $0.421B 0.00
DBV Technologies S.A (DBVT) France $0.411B 0.00
Verastem (VSTM) United States $0.411B 0.00
Selecta Biosciences (SELB) United States $0.399B 0.00
Athersys (ATHX) United States $0.397B 0.00
ANI Pharmaceuticals (ANIP) United States $0.397B 10.09
AMMO (POWW) United States $0.396B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.394B 0.00
Cue Biopharma (CUE) United States $0.385B 0.00
CytomX Therapeutics (CTMX) United States $0.363B 0.00
Innate Pharma S.A (IPHA) France $0.363B 0.00
NextCure (NXTC) United States $0.360B 0.00
Cellular Biomedicine (CBMG) United States $0.348B 0.00
Trevena (TRVN) United States $0.342B 0.00
Arbutus Biopharma (ABUS) United States $0.342B 0.00
Fortress Biotech (FBIO) United States $0.335B 0.00
Voyager Therapeutics (VYGR) United States $0.334B 8.58
Lineage Cell Therapeutics (LCTX) United States $0.325B 0.00
Kamada (KMDA) Israel $0.322B 15.06
Paratek Pharmaceuticals (PRTK) United States $0.308B 0.00
ChromaDex (CDXC) United States $0.288B 0.00
CorMedix Inc (CRMD) United States $0.286B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
IBio (IBIO) United States $0.280B 0.00
Bellus Health (BLU) Canada $0.271B 0.00
Aptinyx (APTX) United States $0.241B 0.00
HOOKIPA Pharma (HOOK) United States $0.240B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.237B 0.00
Cogent Biosciences (COGT) United States $0.231B 0.00
Checkpoint Therapeutics (CKPT) United States $0.229B 0.00
Gritstone Oncology (GRTS) United States $0.225B 0.00
Eton Pharmaceuticals (ETON) United States $0.221B 0.00
Exicure (XCUR) United States $0.219B 0.00
GENFIT S.A (GNFT) France $0.209B 0.00
Pluristem Therapeutics (PSTI) Israel $0.209B 0.00
Cerecor (CERC) United States $0.206B 0.00
Clearside Biomedical (CLSD) United States $0.203B 0.00
TELA Bio (TELA) United States $0.202B 0.00
Biofrontera AG (BFRA) Germany $0.201B 0.00
Theratechnologies (THTX) Canada $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.200B 0.00
VolitionRX (VNRX) United States $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.198B 0.00
Kindred Biosciences (KIN) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.196B 0.00
Abeona Therapeutics (ABEO) United States $0.195B 0.00
DiaMedica Therapeutics (DMAC) United States $0.184B 0.00
Lumos Pharma (LUMO) United States $0.184B 0.00
Nicox SA (NICXF) France $0.182B 0.00
Palatin Technologies (PTN) United States $0.177B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Oncobiologics (OTLK) United States $0.156B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.156B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Evogene (EVGN) Israel $0.153B 0.00
TRACON Pharmaceuticals (TCON) United States $0.153B 0.00
Idera Pharmaceuticals (IDRA) United States $0.153B 0.00
Aptevo Therapeutics (APVO) United States $0.148B 0.00
Catalyst Biosciences (CBIO) United States $0.147B 0.00
Enzo Biochem (ENZ) United States $0.143B 0.00
Prima BioMed (IMMP) Australia $0.137B 0.00
Protalix BioTherapeutics (PLX) Israel $0.132B 0.00
Liquidia Technologies (LQDA) United States $0.130B 0.00
AIT Therapeutics (XAIR) United States $0.126B 0.00
PHASEBIO PHARMA (PHAS) United States $0.125B 0.00
Orgenesis (ORGS) United States $0.124B 256.00
Ecology Coatings (ABVC) United States $0.122B 0.00
Prometic Life Sciences (LMNL) Canada $0.120B 0.00
Applied Genetic Technologies (AGTC) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
Cyclerion Therapeutics (CYCN) United States $0.116B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.114B 0.00
Synlogic (SYBX) United States $0.114B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.105B 0.00
Vascular Biogenics (VBLT) Israel $0.101B 0.00
Organovo Holdings (ONVO) United States $0.099B 0.00
MiRagen Therapeutics (MGEN) United States $0.097B 0.00
Novogen (KZIA) Australia $0.097B 0.00
Aytu Bioscience (AYTU) United States $0.097B 0.00
ARAVIVE, INC (ARAV) United States $0.092B 0.00
CytRx (CYTR) United States $0.088B 0.00
CollPlant Holdings (CLGN) Israel $0.082B 0.00
Stealth BioTherapeutics (MITO) United States $0.079B 37.75
Seelos Therapeutics (SEEL) United States $0.077B 0.00
Adocia (ADOCY) France $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.070B 0.00
Purple Biotech (PPBT) Israel $0.068B 0.00
AnPac Bio-Medical Science (ANPC) China $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Emmaus Life Sciences (EMMA) United States $0.060B 0.00
Genetic Technologies (GENE) Australia $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Yumanity Therapeutics (YMTX) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.055B 0.00
Happiness Biotech Group (HAPP) China $0.054B 0.00
Edesa Biotech (EDSA) Canada $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.051B 0.00
Acorda Therapeutics (ACOR) United States $0.051B 0.00
Cleveland BioLabs (CBLI) United States $0.049B 0.00
BioCardia (BCDA) United States $0.047B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Soligenix (SNGX) United States $0.043B 0.00
AEterna Zentaris (AEZS) United States $0.043B 0.00
Chanticleer Holdings (SONN) United States $0.043B 0.00
Advaxis (ADXS) United States $0.042B 0.00
ATyr Pharma (LIFE) United States $0.042B 0.00
Spherix (AIKI) United States $0.041B 0.00
Prana Biotechnology (ATHE) Australia $0.040B 0.00
IMMURON (IMRN) Australia $0.039B 0.00
Celsion (CLSN) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.028B 0.00
Neuralstem (SNCA) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
CTD Holdings (CYTH) United States $0.009B 0.00
Enveric Biosciences (ENVB) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.004B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00